Beam Therapeutics Inc (BEAM) expanding its growth trajectory ahead
With 5.15 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.28 million shares. The 52-week range on BEAM shows that it touched its highest point at $35.25 and its lowest point at $13.52 during that stretch. It currently has a 1-year price target of $44.31. Beta for […]
A History of Outperforming Analyst Forecasts and Beating the Odds: Beam Therapeutics Inc (BEAM)
With 1.54 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.2 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $20.19 whereas the lowest price it dropped to was $19.32. The 52-week range on BEAM shows […]
A History of Outperforming Analyst Forecasts and Beating the Odds: Beam Therapeutics Inc (BEAM)
With 3.28 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.13 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $19.475 whereas the lowest price it dropped to was $16.6556. The 52-week range on BEAM shows […]
There is no doubt that Beam Therapeutics Inc (BEAM) ticks all the boxes.
With 2.89 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.04 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $17.21 whereas the lowest price it dropped to was $15.7501. The 52-week range on BEAM shows […]
An analyst sees good growth prospects for Beam Therapeutics Inc (BEAM)
With 5.49 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.82 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $16.665 whereas the lowest price it dropped to was $14.72. The 52-week range on BEAM shows […]
Nothing is Better Than Beam Therapeutics Inc (BEAM) stock at the moment
With 2.51 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.52 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $23.43 whereas the lowest price it dropped to was $22.14. The 52-week range on BEAM shows […]
Beam Therapeutics Inc (BEAM) expanding its growth trajectory ahead
With 2.17 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.51 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $25.805 whereas the lowest price it dropped to was $23.94. The 52-week range on BEAM shows […]
A new trading data show Beam Therapeutics Inc (BEAM) is showing positive returns.
With 1.33 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.3 million shares. The 52-week range on BEAM shows that it touched its highest point at $39.14 and its lowest point at $20.84 during that stretch. It currently has a 1-year price target of $48.50. Beta for […]
Wall Street analysts’ outlook for Beam Therapeutics Inc (BEAM)
With 1.42 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.23 million shares. The 52-week range on BEAM shows that it touched its highest point at $45.79 and its lowest point at $20.84 during that stretch. It currently has a 1-year price target of $48.50. Beta for […]
